LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged objective indicia · clear

PTAB

PTAB Faulted on Objective Indicia Analysis

Unpacking the Importance of the Claimed Invention from Other Commercial Components Objective indicia of non-obviousness, such as commercial success and industry praise, can be probative evidence of non-obviousness. In order for the objective evidence of…

August 4, 2021·PTAB·2 min read
PTAB

PTAB Denies Petition Overlooking Objective Indicia of Non-Obviousness

Unrebutted Secondary Indicia Considered in Assessing Becton-Dickinson Factors The submission of so-called “objective indicia of non-obviousness” at the PTAB is rarely effective, especially in the predictable arts (i.e., mechanical/electrical) .…

September 19, 2019·PTAB·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.